Notwithstanding the absence of a correlation between the extent of EZH2 expression and clinical parameters under consideration, it is evident that the majority of the evaluated cSCC tumor tissue samples exhibited EZH2 expression. This evidence concerns the gene EZH2 and skin squamous cell carcinoma.